Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

OXYPHENBUTAZONE 100MG TABLETS 100 MG — DIN 02232754

OXYPHENBUTAZONE : 100 MG · LABORATOIRES CONFAB INC · TABLET · wholesale supply in Canada

Health Canada status: CANCELLED PRE MARKET

What is OXYPHENBUTAZONE 100MG TABLETS?

OXYPHENBUTAZONE 100MG TABLETS 100 MG contains OXYPHENBUTAZONE : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 02232754, held by LABORATOIRES CONFAB INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as cancelled pre market, status dated 09-Apr-2021. This Drug Identification Number is no longer authorized for sale in Canada, so Nexara does not supply it. The record is kept here because buyers still meet the number on old formularies, purchase orders and tender documents; Nexara can help identify an authorized alternative.

Is there a generic Oxyphenbutazone in Canada, and who makes it?

Every market authorization holder with a Canadian DIN for this molecule, and how many of their listings Health Canada currently shows as marketed.

2 holders have a Canadian DIN containing Oxyphenbutazone, across 2 DINs, of which 0 are currently marketed. Marketed count is the number that matters: an approval that is not marketed cannot be bought.

Market authorization holderDINsMarketedBrand namesPosition
ICN CANADA LTD.10OXYBUTAZONE TAB 100MGNo marketed DIN
LABORATOIRES CONFAB INC10OXYPHENBUTAZONE 100MG TABLETSNo marketed DIN

Health Canada’s Drug Product Database does not flag which listing is the originator and which are subsequent-entry products, so Nexara does not label them here. Interchangeability is determined provincially, not federally — confirm for your province before a formulary switch. Nexara can confirm which of these is actually obtainable, and on what lead time, per order.

How is it supplied and stored?

Pack configuration, storage class and the handling constraints that drive cold-chain planning. One DIN can cover more than one pack size, and the pack — not the DIN — is what gets priced, shipped and invoiced.

Strength on the label100 MG
Dosage formTABLET
RouteORAL

Pack detail is kept as a regulatory record. This DIN is no longer authorized for sale in Canada, so Nexara does not quote this pack.

Substance and classification

Active substanceOxyphenbutazone
ATC codeM01AA03
AHFS class28:08.04.92
Biosimilar biologicNo

Health Canada record and identifiers

The regulatory facts straight from the Drug Product Database, plus every identifier form Nexara accepts on a purchase order. A DIN written without its leading zeros is the commonest reason an order line fails to match.

DIN (8-digit, as used in ordering)02232754
DIN (unpadded, as printed on some documents)2232754
Brand nameOXYPHENBUTAZONE 100MG TABLETS
Generic / active ingredientOXYPHENBUTAZONE : 100 MG
Market authorization holderLABORATOIRES CONFAB INC
Health Canada schedulePrescription
ATC codeM01AA03
ATC anatomical main groupM — Musculo-skeletal system
ATC therapeutic subgroupM01AA
Current statusCANCELLED PRE MARKET
Status date09-Apr-2021
Status sourceLive Health Canada DPD sync

Verify on the primary sources

Health Canada DPD record

What can be used instead?

Alternatives on every axis a buyer actually considers — the same molecule in another presentation, the same class, an adjacent class, or a fixed-dose combination. Every row is led by the marketed DIN count, because that is what can be bought this week.

1 · Same molecule, other Canadian presentations

0 of 2 Canadian DINs for this molecule are currently marketed. Marketed products are listed first.

ProductStrengthFormHolderHealth Canada statusDIN
OXYBUTAZONE TAB 100MG100 MGTABLETICN CANADA LTD.CANCELLED POST MARKET00356999

2 · Same class — other molecules in ATC M01AA

MoleculeCanadian brandsDINsMarketedSourceable
Phenylbutazone, CombinationsALKA PHENYL TAB · ALKA PHENYLBUTAZONE TAB · PHENYLONE PLUS TAB30Not in Canada
OxyphenbutazoneOXYBUTAZONE TAB 100MG · OXYPHENBUTAZONE 100MG TABLETS20Not in Canada
PhenylbutazoneAPO PHENYLBUTAZONE TAB 100MG · NOVO-BUTAZONE TAB 100MG20Not in Canada

A molecule with zero marketed DINs cannot be sourced domestically, however many approvals it holds — if one of these sits on a formulary or in an older protocol, that is the line to check.

3 · Adjacent classes in ATC M01A

ATC subgroupMoleculesDINsMarketed
M01AEFenoprofen · Flurbiprofen · Ibuprofen · Ibuprofen, Combinations · Ketoprofen · +5 more398101
M01ABDiclofenac · Diclofenac, Combinations · Etodolac · Indometacin · Ketorolac · +2 more17038
M01AHCelecoxib · Rofecoxib7230
M01ACMeloxicam · Piroxicam · Tenoxicam6714
M01AGMefenamic Acid71
M01AXNabumetone121

Not clinical advice. These tables describe what can be supplied in Canada, not what should be prescribed. Substitution within or across classes is a prescriber and pharmacist decision, and interchangeability is determined provincially.

Can this still be bought in Canada?

No. This Drug Identification Number is cancelled pre market in Health Canada's Drug Product Database, so the product is no longer authorized for sale in Canada and Nexara does not supply it. This page is kept as a regulatory record.

If you are looking for a current equivalent, the alternatives above list every product sharing this therapeutic class, with the marketed ones first. Ask us to source an alternative

Ordering questions

Who can buy this from Nexara?

Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address. Patients and unlicensed buyers are routed to a partner pharmacy.

Is there a minimum order?

Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.

What is the lead time?

Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.

Why is there no price on this page?

Nexara quotes a delivered Canadian price per order, against a verified licence. Foreign list prices are published on incompatible bases and are not a guide to what any buyer can obtain here, so this page shows which markets list the molecule and on what basis, and nothing more.

Can Nexara supply this for a clinical trial?

Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.

Sources and disclaimer

Product data sourced from the Health Canada Drug Product Database. Health Canada status reconciled against the live DPD sync. Last reviewed 10 Sep 2026.

Nothing on this page is medical advice. Nexara Health is a licensed wholesale distributor and supplies licensed entities only; consumer orders are routed to a partner pharmacy. Alternatives tables describe supply, not clinical equivalence.

Health Canada Drug Product Database (DPD), DIN 02232754. Last reviewed 2026-09-10. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.